Quest Launches Mobile Phlebotomy Service for At-Home Specimen Collection
Quest Mobile is a service designed to make it easier and more convenient for patients to have a specimen collected for lab testing nationwide.
Read More
Search Results for: prostate cancer
Urine Biomarkers Can Outperform Serum Biomarkers in Certain Diseases
Researchers reported the enhanced performance of urinary biomarkers compared to plasma biomarkers for disease detection.
Read More
Cytovale Unveils Commercial Launch of Sepsis Test for Emergency Departments
Cytovale announced the U.S. commercial launch of the IntelliSep sepsis test following FDA 510(k) clearance in December 2022.
Read More
EDP Biotech, New Day Diagnostics Announce Merger
EDP Biotech Corp. and New Day Diagnostics LLC announced their strategic merger, joining together to focus on the expedited development and commercialization of diagnostic tests.
Read More
Cleveland Diagnostics’ New Facility will Feature IsoPSA Testing
Cleveland Diagnostics, a biotechnology company developing next-gen diagnostic tests for early detection of cancers, opened a new facility.
Read More